Related Experiment Video
Updated: May 13, 2026

07:42
Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
Published on: October 13, 2015
Simple resazurin-based microplate assay for measuring Chlamydia infections
1Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA.
Antimicrobial Agents and Chemotherapy
|March 20, 2013
Summary
A new alamarBlue assay offers a faster, scalable method for quantifying Chlamydia infections. This approach measures host cell redox activity, simplifying analysis for drug discovery screens.
Area of Science:
- Microbiology
- Cell Biology
- Assay Development
Background:
- Traditional Chlamydia infection quantification relies on manual fluorescence microscopy, which is time-consuming and unsuitable for large-scale screening.
- High-throughput screening for Chlamydia inhibitors necessitates a more efficient and scalable quantification method.
Purpose of the Study:
- To develop and validate a rapid, high-throughput assay for quantifying Chlamydia infection.
- To adapt the alamarBlue (resazurin) assay for measuring Chlamydia burden in host cells.
Main Methods:
- Utilized the alamarBlue (resazurin) assay to assess the metabolic activity of Chlamydia-infected host cells.
- Performed measurements in a standard 96-well plate format for compatibility with high-throughput screening.
- Compared results obtained from the alamarBlue assay with conventional fluorescence microscopy.
Main Results:
- The alamarBlue assay effectively measured Chlamydia infection levels by reflecting host cell redox capability.
- Results from the alamarBlue assay demonstrated comparability to the established fluorescence microscopy method.
- The alamarBlue assay significantly reduced the time required for Chlamydia infection analysis.
Conclusions:
- The alamarBlue assay provides a viable, time-efficient alternative to manual microscopy for quantifying Chlamydia infections.
- This assay is suitable for large-scale screening applications, including inhibitory compound screens against Chlamydia.

